8 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Terminated 8 |
Follow Fluticasone: new trials by email Literature Review of Fluticasone trials Research Report on Fluticasone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Intermittent Tiotropium in Early Childhood Wheezing Tiotropium Bromide, Fluticasone Propionate, Salbutamol - Wheezy Bronchitis, Asthmatic Bronchitis | Phase 4 | Terminated | Helsinki University Central Hospital | 80 | 2016-04-20 | 2024-09-19 |
| Study of Safety of Foradil in Patients With Persistent Asthma Formoterol 12 mcg, Fluticasone propionate 100 mcg, Fluticasone propionate 250 mcg - Persistent Asthma | Phase 4 | Terminated | Novartis Pharmaceuticals | 827 | 2013-05-01 | 2017-03-21 |
| Study Of RV-39 In Patients Who Also Have Asthma fluticasone propionate/salmeterol, fluticasone propionate, placebo - Asthma | Phase 4 | Terminated | GlaxoSmithKline | 16 | 2007-10-01 | 2016-12-28 |
| ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies. Salmeterol, Fluticasone Propionate/Salmeterol Combination Product - Pulmonary Disease, Chronic Obstructive | Phase 4 | Terminated | GlaxoSmithKline | 180 | 2006-12-01 | 2016-10-28 |
| Asthma/Steroid Withdrawal Study inhaled corticosteroid - Asthma | Phase 4 | Terminated | University of Alberta | 6 | 2006-10-01 | 2016-05-26 |
| The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis Placebo, Montelukast, Fluticasone propionate - Rhinitis, Allergic, Perennial | Phase 4 | Terminated | University of Chicago | 102 | 2005-07-01 | 2014-02-28 |
| Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients Qvar, Flovent Diskus - Asthma | Phase 4 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 49 | 2004-01-31 | 2021-11-24 |
| Modification Of Disease Outcome In COPD fluticasone 500 mcg, fluticasone 500 mcg + salmeterol 50 mcg - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Leiden University Medical Center | 200 | 2000-04-01 | 2006-01-20 |
Asthma (4) · Pulmonary Disease, Chronic Obstructive (2) · Airway Obstruction (1) · Bronchiolitis (1) · Dyspnea (1) · Inflammation (1) · Respiratory Sounds (1) · Rhinitis, Allergic, Perennial (1)
GlaxoSmithKline (2) · Helsinki University Central Hospital (1) · Leiden University Medical Center (1) · Novartis Pharmaceuticals (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · University of Alberta (1) · University of Chicago (1)
United States (5) · Canada (1) · Finland (1) · Netherlands (1)
Chrsitopher Compton (1) · Irvin Mayers, MD, FRCPC (1) · Peter J. Sterk, MD, PhD (1) · Robert M Naclerio, MD (1)
PMID 18039368, PMID 19841453, PMID 20674827, PMID 23667615, PMID 25836351, PMID 26659582, PMID 26696093, PMID 33060632, PMID 35118915, PMID 35942814, PMID 40739568
2015 (1)